A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...

Indian drug companies are preparing to launch low-cost versions of Novo Nordisk’s Wegovy and Ozempic as patents expire in 2026, making weight-loss and diabetes treatment more affordable worldwide.

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Data brief analyzes patenting and pricing practices for blockbuster drugs Eliquis and semaglutide medications (Ozempic, Rybelsus, Wegovy), continuing the acclaimed Overpatented, Overpriced series that ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Frozen food giant Conagra introduces new product lineup amid sales declines as consumers increasingly cook at home and quick-service restaurants promote competitive deals.

SO-CALLED “miracle” weight-loss jabs are far less effective in the real world than in clinical trials, a major study has revealed. The new findings could have big implications for Brits ...

AS electrical pulses surge into my bottom, I peer over my shoulder and see my cheeks going like the clappers. But just as I thought the sight of my sagging glutes bouncing up and down like a pair ...

Denmark-based multinational pharmaceutical company Novo Nordisk will be making available in the Philippines within this year ...